“Observer investigation shows that majority of Nice drug appraisals involve groups financially linked to maker of pharmaceuticals“ Shanti Das and Jon Ungoed-Thomas report for The Observer: “Drug companies are systematically funding grassroots patient groups that lobby the NHS medicines watchdog to approve…
Read more
Since July 2017 the Society for Psychotherapy Research (SPR) UK has been leading a major stakeholder campaign calling on the National Institute of Health and Care Excellence (NICE) to conduct a “full and proper revision” of its 2009 guidelines on the Recognition and…
Read more
The Guardian newspaper reports: “Half of all those taking antidepressants experience withdrawal problems when they try to give them up and for millions of people in England, these are severe, according to a new review of the evidence commissioned by MPs. Guidance…
Read more
The BBC says (May 23rd, 2018): “Two years ago, Dr Chris van Tulleken discovered we are taking more prescription drugs than ever before – a billion prescriptions a year in the UK. He worked with a GP (General Practice) surgery…
Read more
Although several years old, this paper – “NICE Under Scrutiny” still has great relevance. It looks at the impact of the National Institute for Health and Clinical Excellence (NICE) guidelines on the provision of counselling/psychotherapy in the UK. Produced by…
Read more